SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-23-004283
Filing Date
2023-01-23
Accepted
2023-01-23 08:10:29
Documents
1
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 6191
  Complete submission text file 0001213900-23-004283.txt   7598
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Issuer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11 REUVEN SHARI ST. JERUSALEM L3 9724611
Business Address
Laster Morris C (Reporting) CIK: 0001854619 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37353 | Film No.: 23542559